Literature DB >> 9065412

Identification of two essential phosphorylated threonine residues in the catalytic domain of Mekk1. Indirect activation by Pak3 and protein kinase C.

Y L Siow1, G B Kalmar, J S Sanghera, G Tai, S S Oh, S L Pelech.   

Abstract

The 78-kDa protein kinase Mekk1 plays an important role in the stress response pathway that involves the activation of downstream kinases Sek1 and stress-activated protein kinase/c-Jun NH2-terminal kinase. Conserved serine and threonine residues located between the kinase subdomains VII and VIII of many protein kinases are phosphorylated for maximal kinase activation. Two threonine residues within this region in Mekk1 at positions 560 and 572, but not the serine at 557, were shown to be essential for catalytic activity in this study. When these threonine residues were replaced with alanine, there was a significant loss in phosphotransferase activity toward the primary substrate, Sek1, and a large decrease in autophosphorylation activity. Site-directed mutagenesis demonstrated that these threonine residues cannot be replaced with either serine or glutamic acid for preservation of phosphotransferase activity. Further examination of the Mekk1 mutants isolated from 32P-labeled transfected COS cells showed that Thr-560 and Thr-572 were indeed phosphorylated after two-dimensional tryptic-chymotryptic phosphopeptide analysis. Additional determinants in the NH2-terminal domain of Mekk1 also play a role in the regulation of Mekk1 activity. Although Pak3 and PKC can activate Mekk1 in vivo, this interaction is indirect and independent, since there was no direct phosphorylation of Mekk1 by Pak3 or PKC or of Pak3 by PKC, respectively.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065412     DOI: 10.1074/jbc.272.12.7586

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Protein kinases as therapeutic targets.

Authors:  R Sridhar; O Hanson-Painton; D R Cooper
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

2.  Activation of the yeast SSK2 MAP kinase kinase kinase by the SSK1 two-component response regulator.

Authors:  F Posas; H Saito
Journal:  EMBO J       Date:  1998-03-02       Impact factor: 11.598

Review 3.  c-Jun, at the crossroad of the signaling network.

Authors:  Qinghang Meng; Ying Xia
Journal:  Protein Cell       Date:  2011-12-17       Impact factor: 14.870

4.  MAP3K1: Genomic Alterations in Cancer and Function in Promoting Cell Survival or Apoptosis.

Authors:  Trang T Pham; Steven P Angus; Gary L Johnson
Journal:  Genes Cancer       Date:  2013-11

5.  Direct activation of mitogen-activated protein kinase kinase kinase MEKK1 by the Ste20p homologue GCK and the adapter protein TRAF2.

Authors:  Deborah N Chadee; Takashi Yuasa; John M Kyriakis
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

6.  The inhibitory effects of PKCθ on adiponectin expression is mediated by ERK in 3T3-L1 adipocytes.

Authors:  S Sun; Y Liu; J Lu; A Omar; S Sun; Y Bi; C Wang
Journal:  J Endocrinol Invest       Date:  2010-03-25       Impact factor: 4.256

7.  Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase D1.

Authors:  Rüdiger Arnold; Irene M Patzak; Brit Neuhaus; Sadia Vancauwenbergh; André Veillette; Johan Van Lint; Friedemann Kiefer
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

8.  MEKK1/JNK signaling stabilizes and activates p53.

Authors:  S Y Fuchs; V Adler; M R Pincus; Z Ronai
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

9.  Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway.

Authors:  Taisuke Kajino; Hong Ren; Shun-Ichiro Iemura; Tohru Natsume; Bjarki Stefansson; David L Brautigan; Kunihiro Matsumoto; Jun Ninomiya-Tsuji
Journal:  J Biol Chem       Date:  2006-11-01       Impact factor: 5.157

10.  Molecular determinants of NF-kappaB-inducing kinase action.

Authors:  X Lin; Y Mu; E T Cunningham; K B Marcu; R Geleziunas; W C Greene
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.